Summary:

Peripheral T-Cell Lymphoma Study Now Enrolling Volunteers
Volunteer for a study testing the safety and effectiveness of a JAK1 inhibitor to prevent Peripheral T-Cell Lymphoma
See If You May Qualify for This Study by Answering a Few Short Questions
For more information learn more about this study today!